LPTX
NSCLeap Therapeutics Inc.
Healthcare•Biotechnology
Watchlist:
Last updated: Monday 7th July 2025
0.29
+0.00 (1.18%)
Prev Close:0.288
Open:0.2839
Bid:0.28
Ask:0.2994
52 Week Range
0.224.79
Volume:1,255,180
Mkt Cap:12 M
24
MarketXLS Rank ®
Weak Hold
Price Target
$0.34
+16.7%
Financials
Financial Statements
LPTX - Cash Flow (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Invalid date | |
|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure Reported | 100000.0 | 64000.0 | |||||||
| Cash Flow From Continuing Investing Activities | 49 M | 25000.0 | -85000.0 | -64000.0 | |||||
| Change In Account Payable | 902000.0 | 712000.0 | 945000.0 | 4 M | -3 M | 368000.0 | 1 M | ||
| Change In Income Tax Payable | 562000.0 | ||||||||
| Change In Payables And Accrued Expense | 1 M | 712000.0 | 945000.0 | 4 M | -3 M | 368000.0 | 1 M | ||
| Change In Prepaid Assets | 100000.0 | 164000.0 | 416000.0 | -639000.0 | 774000.0 | 302000.0 | -297000.0 | -99000.0 | |
| Change In Tax Payable | 562000.0 | ||||||||
| Change In Working Capital | 2 M | 2 M | 758000.0 | 3 M | -363000.0 | 299000.0 | -277000.0 | 836000.0 | |
| Common Stock Payments | -210000.0 | -184000.0 | -2 M | ||||||
| Depreciation And Amortization | 420000.0 | 427000.0 | 16000.0 | 29000.0 | 668000.0 | 47000.0 | 49000.0 | 48000.0 | |
| Financing Cash Flow | 37 M | -30000.0 | -210000.0 | 98 M | 74 M | 15 M | 16 M | 48 M | |
| Issuance Of Capital Stock | 49 M | 12 M | 28 M | ||||||
| Issuance Of Debt | 750000.0 | ||||||||
| Net Business Purchase And Sale | 49 M | ||||||||
| Net Common Stock Issuance | -210000.0 | -184000.0 | 47 M | 12 M | 28 M | ||||
| Net Foreign Currency Exchange Gain Loss | 42000.0 | 13000.0 | 608000.0 | 379000.0 | -738000.0 | -126000.0 | |||
| Net Issuance Payments Of Debt | 750000.0 | ||||||||
| Net PPE Purchase And Sale | 25000.0 | -85000.0 | -64000.0 | ||||||
| Net Preferred Stock Issuance | 54 M | ||||||||
| Other Non-cash Items | 5 M | 36 M | 4 M | 2 M | 2 M | 4 M | -4 M | 5 M | |
| Preferred Stock Issuance | 54 M | ||||||||
| Proceeds From Issuance Of Warrants | -29000.0 | 993000.0 | 348000.0 | 1 M | |||||
| Proceeds From Stock Option Exercised | 4000.0 | 51000.0 | 14000.0 | 20000.0 | |||||
| Purchase Of PPE | -100000.0 | -64000.0 | |||||||
| Sale Of Business | 50 M | ||||||||
| Sale Of PPE | 25000.0 | 15000.0 | |||||||
| Short Term Debt Issuance | 750000.0 | ||||||||
| Stock Based Compensation | 6 M | 5 M | 5 M | 4 M | 3 M | 4 M | 3 M | 6 M | |
| Amord | 415000.0 | 412000.0 | 399000.0 | 527000.0 | 634000.0 | ||||
| Begcash | 115 M | 52 M | 4 M | 16 M | 26 M | 793000.0 | |||
| Capex | 25000.0 | -85000.0 | -64000.0 | ||||||
| Cffcf | 37 M | -30000.0 | -210000.0 | 98 M | 101 M | 12 M | 872000.0 | 27 M | |
| Cffinv | 49 M | 25000.0 | -85000.0 | -64000.0 | |||||
| Cffoa | -60 M | -44 M | -49 M | -35 M | -26 M | -29 M | -27 M | -24 M | |
| Chgcash | -23 M | 5 M | -49 M | 63 M | 48 M | -12 M | -9 M | 2 M | |
| Chgothca | 152000.0 | 11000.0 | -36000.0 | -3000.0 | 20000.0 | -158000.0 | |||
| Chgothcl | -1 M | 2 M | |||||||
| Chgothwc | 143000.0 | 748000.0 | -755000.0 | 806000.0 | |||||
| Chgpay | 1 M | 712000.0 | 945000.0 | 4 M | -3 M | 368000.0 | 1 M | ||
| Comstkiss | 49 M | 12 M | 28 M | ||||||
| Depamor | 5000.0 | 15000.0 | 16000.0 | 29000.0 | 34000.0 | 47000.0 | 49000.0 | 48000.0 | |
| Effexch | -43000.0 | -162000.0 | -33000.0 | 115000.0 | -223000.0 | 674000.0 | -618000.0 | ||
| Endcash | -60 M | -44 M | 66 M | 115 M | 52 M | 4 M | 16 M | 3 M | |
| Fcf | -60 M | -44 M | -49 M | -35 M | -26 M | -27 M | -26 M | -22 M | |
| Netinccont | -68 M | -81 M | -55 M | -41 M | -28 M | -33 M | -23 M | -30 M | |
| Netothfin | -1000.0 | 97 M | -437000.0 | -359000.0 | -2 M | ||||
| Netstdebtiss | 750000.0 | ||||||||
| Opcf | -60 M | -44 M | -49 M | -35 M | -26 M | -27 M | -26 M | -22 M | |
| Opgainloss | 42000.0 | 13000.0 | 608000.0 | 379000.0 | -738000.0 | -126000.0 | |||
| Purchbus | -1 M | ||||||||
| Repurchstk | -210000.0 | -184000.0 | -2 M |
Call: 1-877-778-8358 
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.
I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...
MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.
I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.